NK-Cell Lymphoma: Clinical Trials

5 trials for NK-Cell Lymphoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 2 unknown, 1 completed. 1 Early Phase 1, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Early Phase 11Recruiting 1
Not applicable1Completed 1
Phase 21Unknown 1

Follow NK-Cell Lymphoma: new trials by email Literature Review of NK-Cell Lymphoma trials Research Report on NK-Cell Lymphoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Registry for People With T-cell Lymphoma
Optional Blood Sample and Nail Sample - T-cell Lymphoma, NK-Cell Lymphoma
RecruitingMemorial Sloan Kettering Cancer Center10002023-07-272026-05-20
Screening for Oculocerebral Lymphoma With the Phenotype of NK Cells in Patients With Uveitis
Blood sample - Uveitis, Lymphoma
Not applicableCompletedHospices Civils de Lyon602022-06-012026-09-01
Chemoimmunotherapy and Allogeneic Stem Cell Transplant for NK T-cell Leukemia/Lymphoma
Methotrexate, pralatraxate,, Ifosfamide - NK-Cell Lymphoma, NK-Cell Leukemia
Early Phase 1RecruitingNew York Medical College402019-03-012026-08-18
Pembrolizumab for T/NK-cell lymphomasNK-cell Lymphomas
pembrolizumab - T-Cell Lymphoma, NK-Cell Lymphoma
Phase 2UnknownThe University of Hong Kong332016-12-012019-04-17
T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients
T-cell Lymphoma, NK-Cell Lymphoma
UnknownGrupo de Estudos Multicentricos em Onco-Hematologia5002015-01-012017-07-05

Narrower conditions

Lymphoma, T-Cell (3)  ·  Leukemia, Large Granular Lymphocytic (2)  ·  Enteropathy-Associated T-Cell Lymphoma (1)  ·  Immunoblastic Lymphadenopathy (1)  ·  Leukemia, Prolymphocytic, T-Cell (1)  ·  Lymphoma (1)  ·  Lymphoma, Extranodal NK-T-Cell (1)  ·  Lymphoma, Large-Cell, Anaplastic (1)  ·  Lymphoma, Primary Cutaneous Anaplastic Large Cell (1)  ·  Lymphoma, T-Cell, Cutaneous (1)  ·  Lymphoma, T-Cell, Peripheral (1)  ·  Mycosis Fungoides (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Sezary Syndrome (1)  ·  Subcutaneous panniculitis-like T-cell lymphoma (1)

Broader conditions

Hemic and Lymphatic Diseases (5)  ·  Immune System Diseases (5)  ·  Immunoproliferative Disorders (5)  ·  Lymphatic Diseases (5)  ·  Lymphoproliferative Disorders (5)  ·  Neoplasms (5)  ·  Neoplasms by Histologic Type (5)  ·  Lymphoma (4)  ·  Lymphoma, Non-Hodgkin (4)  ·  Hematologic Diseases (2)  ·  Leukemia (2)  ·  Leukemia, Lymphoid (2)  ·  Leukemia, T-Cell (2)  ·  Eye Diseases (1)  ·  Leukemia, Prolymphocytic (1)

Interventions

Blood Specimen Collection (1)  ·  Brentuximab Vedotin (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Etoposide (1)  ·  Ifosfamide (1)  ·  Methotrexate (1)  ·  Prednisone (1)  ·  calaspargase pegol (1)  ·  pembrolizumab (1)

Sponsors

Grupo de Estudos Multicentricos em Onco-Hematologia (1)  ·  Hospices Civils de Lyon (1)  ·  Memorial Sloan Kettering Cancer Center (1)  ·  New York Medical College (1)  ·  The University of Hong Kong (1)

Countries

United States (2)  ·  France (1)  ·  Hong Kong (1)

Top investigators

Eliana CM Miranda, M.Ed.; Ph.D. (1)  ·  Eric Tse, PhD(Cantab) (1)  ·  Mitchell Cairo, MD (1)  ·  Steven Horwitz, MD (1)